Such combinational therapy has been shown for alpha1-antitrypsin (AAT) deficiency, in which a hairpin RNA targeting mutated AAT transcript was delivered together with codon-optimized AAT gene [29]. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.